Literature DB >> 29564694

Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.

Isabella P P Grande1, Paulo V G H Amorim1, Ane Caroline Thé B Freire2, Raquel S Jallad2, Nina R Musolino3, Valter A Cescato3, Gilberto O da Silva3, Marcello D Bronstein2, Ericka B Trarbach4,5.   

Abstract

Sirtuins 1-7 (SIRT) are a highly conserved family of histone deacetylases involved in the regulation of longevity that have a considerable impact in transcription, DNA repair regulation, telomeric stability, cell senescence and apoptosis. In the present study, SIRT1-7 mRNA levels were evaluated in 37 somatotropinomas and 31 nonfunctioning pituitary adenomas (NFPAs) using qPCR and relation to tumor size, invasiveness and Ki-67 proliferative index was made. Overexpression of SIRT1 was observed in 86.5% of somatotropinomas versus 41.9% of NFPAs (P < 0.01). SIRT3 was more underexpressed in NFPAs than somatotropinomas (77.4 and 40.5%, respectively, P < 0.01) as well as SIRT4 and SIRT7. Despite the lack of association between sirtuins and invasiveness or Ki-67 index, SIRT1 and SIRT3 expressions were related to tumor size. Mean of the largest diameter was smaller in adenomas with SIRT1 overexpression than with normal expression (P < 0.01) and SIRT3 underexpression was associated with larger tumors (P < 0.01). In conclusion, a pronounced difference in sirtuins expression was identified between pituitary adenomas, suggesting that these genes are potential markers of pituitary adenomas and could be employed in the characterization of somatotropinomas and NFPAs. The role of sirtuins in pathogenesis of pituitary tumors merits further investigation and possibly will provide new molecular insight about their progression.

Entities:  

Keywords:  Histone deacetylases; NFPA; Senescence; Sirtuins; Somatotropinomas; Tumor marker

Mesh:

Substances:

Year:  2018        PMID: 29564694     DOI: 10.1007/s11102-018-0881-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  19 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7.

Authors:  Jia Yu; Bo Qin; Fengying Wu; Sisi Qin; Somaira Nowsheen; Shan Shan; Jacqueline Zayas; Huadong Pei; Zhenkun Lou; Liewei Wang
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

Review 3.  The cytogenesis and pathogenesis of pituitary adenomas.

Authors:  S L Asa; S Ezzat
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

4.  Sirtuins at a glance.

Authors:  Takashi Nakagawa; Leonard Guarente
Journal:  J Cell Sci       Date:  2011-03-15       Impact factor: 5.285

Review 5.  SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model.

Authors:  Yu Wang; Yan Liang; Paul M Vanhoutte
Journal:  FEBS Lett       Date:  2010-12-02       Impact factor: 4.124

6.  SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress.

Authors:  Hyun-Seok Kim; Krish Patel; Kristi Muldoon-Jacobs; Kheem S Bisht; Nukhet Aykin-Burns; J Daniel Pennington; Riet van der Meer; Phuongmai Nguyen; Jason Savage; Kjerstin M Owens; Athanassios Vassilopoulos; Ozkan Ozden; Seong-Hoon Park; Keshav K Singh; Sarki A Abdulkadir; Douglas R Spitz; Chu-Xia Deng; David Gius
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

7.  SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.

Authors:  Jiyung Shin; Ming He; Yufei Liu; Silvana Paredes; Lidia Villanova; Katharine Brown; Xiaolei Qiu; Noushin Nabavi; Mary Mohrin; Kathleen Wojnoonski; Patrick Li; Hwei-Ling Cheng; Andrew J Murphy; David M Valenzuela; Hanzhi Luo; Pankaj Kapahi; Ronald Krauss; Raul Mostoslavsky; George D Yancopoulos; Frederick W Alt; Katrin F Chua; Danica Chen
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

Review 8.  [Molecular aspects of pituitary tumorigenesis].

Authors:  Emilia M Pinto; Marcello D Bronstein
Journal:  Arq Bras Endocrinol Metabol       Date:  2008-06

Review 9.  Nonfunctioning pituitary tumors and pituitary incidentalomas.

Authors:  Mark E Molitch
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 10.  Sirtuins: critical regulators at the crossroads between cancer and aging.

Authors:  L R Saunders; E Verdin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  3 in total

Review 1.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  SIRT1 Contributes as an Invasiveness Marker in Pituitary Adenoma.

Authors:  Domantas Vaiciulis; Alvita Vilkeviciute; Greta Gedvilaite; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  Brain Sci       Date:  2021-12-11

Review 3.  Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.

Authors:  Vinaya Srirangam Nadhamuni; Márta Korbonits
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.